haemonetics share price
Shares of Haemonetics Corporation HAE scaled a new 52-week high of $58.02 on Nov 17, closing nominally lower at $57.99. The company has gained 43.9% in the last six months, much higher than the S&P 500âs gain of 7.8%. Haemonetics has also beat the broader industryâs gain of 7.3%. The stock has a market cap of $3.06 billion. Further, Haemoneticsâ estimate revision trend for the current year is favorable. In the past 30 days, five estimates moved up with no movement in the opposite direction. Consequently, estimates were up from $1.61 per share to $1.70.